Drug Marketing in China and Worldwide (October)(2023)
Drugs have been approved for marketing, and some diseases have been treated.
November 1, 2023
by PharmaSources
Host Genetic Backgrounds Underlie Variable COVID-19 Pathology
Since the advent of the COVID-19 pandemic, tremendous progress has been made in developing effective vaccines against SARS-CoV-2, the coronavirus that causes COVID-19, and in treating ill patients.
September 28, 2021
by prnewswire
World Brain Day 2020 "Moves to End Parkinson's Disease"
On July 22, the World Federation of Neurology (WFN) is partnering with the International Parkinson and Movement Disorder Society to support the 6th Annual World Brain Day. This year, World Brain Day is dedicated to raising awareness for Parkinson's Diseas
July 20, 2020
by prnasia
Greater global cooperation needed to tackle vaccine-preventable diseases in a world with COVID-19
The authors of the study also included researchers at the University of Ghana, Imperial College London, the Center for Global Development Europe, London School of Hygiene & Tropical Medicine and the University of Cambridge.
July 17, 2020
by expresspharma
Researchers call for worldwide biosurveillance network to protect from diseases
The emergence of COVID-19 is a powerful reminder of how unchecked wildlife trade can lead to the spillover spread of viruses between wildlife and humans.
July 10, 2020
by worldpharmanews
New consortium EUbOPEN will provide tools to unlock disease biology
Almost twenty years after deciphering the human genome, our understanding of human disease is still far from complete.
June 10, 2020
by worldpharmanews
Coronavirus: Disease exposure the biggest challenge to healthcare service professionals
Exposure to the disease and lack of enough critical medical devices are the biggest challenges facing healthcare professionals during the coronavirus pandemic, found a Verdict poll.
April 10, 2020
by pharmaceutical-technology
£12m committed to preventable disease research
The National Institute for Health Research (NIHR) has revealed that the UK Government has committed an extra £12 million to the organisation in 2020/21 for research into preventable diseases.
March 16, 2020
by pharmatimes
Sepsis Associated With Almost 20 Percent of Global Deaths
From 1990 to 2017, there was a decrease in sepsis incidence and mortality, although considerable regional variation exists, according to a study published online Jan. 16 in The Lancet.
January 17, 2020
by drugs
Ozone, Wood Smoke Raise Odds of COPD in Smokers and Nonsmokers
High levels of ozone and wood smoke each increase the risk for lung diseases like chronic obstructive pulmonary disease (COPD) among smokers and nonsmokers alike, two new studies find.
January 6, 2020
by drugs
Guidance Developed for Providing Quality STD Care
In a report published in the January issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report ...
January 3, 2020
by drugs
End-Stage Renal Disease Patients at Higher Risk for Syphilis
End-stage renal disease (ESRD) patients are at a higher risk for contracting syphilis, according to a study recently published in the Clinical Kidney Journal.
December 26, 2019
by drugs